Pulmonary surfactant therapy

Francis R Poulain, J. A. Clements

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Surfactant replacement therapy is now an integral part of the care of neonates since several clinical trials of natural surfactant extracts and synthetic preparations have shown efficacy in the treatment of infants with hyaline membrane disease. In these studies, early treatment with exogenous surfactant substantially reduced mortality and the incidence of air leak, although it did not appear to reduce the incidence of other complications, in particular bronchopulmonary dysplasia. Early reports of exogenous surfactant therapy in patients with the adult respiratory distress syndrome, although promising, remain limited in number. More research is needed to improve on current modes of therapy and to investigate the possible role of surfactant in other lung diseases of both newborns and adults.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalWestern Journal of Medicine
Issue number1
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Pulmonary surfactant therapy'. Together they form a unique fingerprint.

Cite this